Roberto Cavallaro

Author PubWeight™ 22.74‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Pharmacogenetics of tardive dyskinesia: combined analysis of 780 patients supports association with dopamine D3 receptor gene Ser9Gly polymorphism. Neuropsychopharmacology 2002 1.23
2 Functional and structural brain correlates of theory of mind and empathy deficits in schizophrenia. Schizophr Res 2009 1.14
3 Psychopathological and neuropsychological correlates of source monitoring impairment in schizophrenia. Psychiatry Res 2007 0.99
4 Combined analysis of 635 patients confirms an age-related association of the serotonin 2A receptor gene with tardive dyskinesia and specificity for the non-orofacial subtype. Int J Neuropsychopharmacol 2005 0.97
5 Influence of catechol-O-methyltransferase Val158Met polymorphism on neuropsychological and functional outcomes of classical rehabilitation and cognitive remediation in schizophrenia. Neurosci Lett 2007 0.96
6 The Brief Assessment of Cognition in Schizophrenia. Normative data for the Italian population. Neurol Sci 2008 0.93
7 The pharmacology and safety of paliperidone extended-release in the treatment of schizophrenia. Expert Opin Drug Saf 2007 0.85
8 Criteria for symptom remission revisited: a study of patients affected by schizophrenia and schizoaffective disorders. BMC Psychiatry 2013 0.83
9 Tardive dyskinesia and DRD2, DRD3, DRD4, 5-HT2A variants in schizophrenia: an association study with repeated assessment. Int J Neuropsychopharmacol 2004 0.83
10 HTTLPR functional polymorphism in schizophrenia: executive functions vs. sustained attention dissociation. Prog Neuropsychopharmacol Biol Psychiatry 2009 0.83
11 Cerebral D2 and 5-HT2 receptor occupancy in Schizophrenic patients treated with olanzapine or clozapine. J Psychopharmacol 2004 0.81
12 Cognitive dysfunction and glutamate reuptake: effect of EAAT2 polymorphism in schizophrenia. Neurosci Lett 2012 0.81
13 Genomics and epigenomics in novel schizophrenia drug discovery: translating animal models to clinical research and back. Expert Opin Drug Discov 2014 0.80
14 Effect of 5-HT1A-receptor functional polymorphism on Theory of Mind performances in schizophrenia. Psychiatry Res 2010 0.80
15 Long-term remission in schizophrenia and schizoaffective disorder: results from the risperidone long-acting injectable versus quetiapine relapse prevention trial (ConstaTRE). Ther Adv Psychopharmacol 2013 0.79
16 Self-awareness of cognitive functioning in schizophrenia: patients and their relatives. Psychiatry Res 2012 0.79
17 COMT and STH polymorphisms interaction on cognition in schizophrenia. Neurol Sci 2014 0.79
18 Theory of mind and emotion processing training for patients with schizophrenia: preliminary findings. Psychiatry Res 2012 0.79
19 Clozapine-induced hypersensitivity myocarditis. Chest 2004 0.78
20 The comprehension of idiomatic expressions in schizophrenic patients. Neuropsychologia 2009 0.78
21 Premorbid functioning and treatment response in recent-onset schizophrenia: prospective study with risperidone long-acting injectable. J Clin Psychopharmacol 2011 0.78
22 COMT Val158Met and 5-HT1A-R -1019 C/G polymorphisms: effects on the negative symptom response to clozapine. Pharmacogenomics 2015 0.77
23 Patterns of evidence integration in schizophrenia and delusion. Psychiatry Res 2012 0.77
24 The effect of verbalization strategy on Wisconsin Card Sorting Test performance in schizophrenic patients receiving classical or atypical antipsychotics. BMC Psychiatry 2006 0.77
25 Saitohin polymorphism and executive dysfunction in schizophrenia. Neurol Sci 2011 0.77
26 Genetic dissection of drug effects in clinical practice: CLOCK gene and clozapine-induced diurnal sleepiness. Neurosci Lett 2004 0.76
27 Exploring effects of EAAT polymorphisms on cognitive functions in schizophrenia. Pharmacogenomics 2014 0.76
28 Theory of Mind intervention for outpatients with schizophrenia. Neuropsychol Rehabil 2013 0.76
29 Catechol-O-methyltransferase (COMT) genotype biases neural correlates of empathy and perceived personal distress in schizophrenia. Compr Psychiatry 2012 0.75
30 The COMT Val158Met polymorphism moderates the association between cognitive functions and white matter microstructure in schizophrenia. Psychiatr Genet 2016 0.75